ReviewReproductive biology and endocrinology : RB&E2026
What might a satisfactory response by journals and publishers to publication integrity concerns look like?
Review in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA reliable biomedical literature is critical to scientific advances and patient care. When concerns about the integrity of a publication are raised, it is very commonly by journal readers. Published evidence reports that responses from publishers to integrity concerns raised by readers are slow, incomplete, inconsistent and opaque. Here, we examine publisher responses and propose a schema for improving them. ANALYSES: Supported by published evidence and examples from our extensive experience in communicating integrity concerns to journal and publishers, we conclude that many aspects of publisher responses to notification of integrity concerns are unsatisfactory. We propose that the quality of publisher responses and the outcomes of their integrity assessments could be improved by the adoption of a proactive and collaborative approach at manuscript submission, a primary focus on publication integrity instead of researcher behaviour, adoption of systematic and unconflicted assessment methodologies, commitment to timely, transparent and comprehensive assessments, timely, respectful communication with journal readers, and timely correction of the published record.
conclusionPublishers, who are ultimately responsible for the integrity of the biomedical literature, could and should substantially improve their response to the receipt of concerns about the integrity of publications in their journals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.